2024 Biotech Layoffs. Biotech layoffs continue to pummel the industry in early 2024 — albeit at a slightly lower clip than in 2023. Guarded optimism seems to be the mood of the biopharmaceutical industry to start 2024.
2023 was a year of economic uncertainty for the biotech industry, which led to a funding drought. Last year, we tallied 187 total layoffs among biotech companies, a 57% jump compared to 119 in 2022.
The Biopharma Industry Will Continue To See Healthy M&Amp;A Activity In 2024, According To A Pwc Report, With Deals Totaling $225 Billion To $275 Billion.
By kara miller — boston globe.
At The End Of June, At Least 54.
Three more biotechnology companies announced layoffs this week, adding to a string of cost.
Will Biotech Layoffs Continue Through 2023?
Images References :
Guarded Optimism Seems To Be The Mood Of The Biopharmaceutical Industry To Start 2024.
And what’s going to move markets in 2024?
Listen To This Article 2 Min.
The biopharma industry will continue to see healthy m&a activity in 2024, according to a pwc report, with deals totaling $225 billion to $275 billion.